NICU point-of-care testing solution
Get support in making well-informed treatment decisions with our NICU solution
Careful monitoring of the neonate
Neonates born premature may present a range of critical conditions that caregivers need to diagnose, treat and monitor. The care that neonates receive in the first hours and days can have a significant impact on their quality of life. [1,2]
In the short term, the recognition and treatment of critical symptoms can save the neonate’s life. [3]
In the long term, when caregivers provide correct and timely treatment and avoid life-altering complications, this helps contribute to better quality of life. [3]
The rapidly changing conditions of the neonate and undetected oxygen changes can be challenging in the neonatal intensive care unit (NICU). The NICU solution supports you in making diagnostic decisions and in caring for neonates.
Our NICU solution supports you in critical decision making
The possibility to change the course of a pre-term neonate's life starts here. By providing you with insight into the neonate's condition, we aim to support you in making well-informed treatment decisions.
The dedicated NICU solution includes:
- blood gas testing on a very small blood sample
- continuous non-invasive transcutaneous monitoring of oxygen and carbon dioxide levels
The combination of advanced technologies and an extensive panel of tests gives you access to accurate and real-time information about the neonate’s condition.
ABL90 FLEX PLUS blood gas analyser
- 19 critical parameters on only 65 microlitres of blood with creatinine and urea
- Dedicated 45 microlitres Micromode measurement for capillary tube samples*
- Results in 35-60 seconds depending on mode
*Excluding creatinine and urea
TCM5 FLEX transcutaneous monitor
- System defined limits for site time vs. temperature help reduce the risk of harm from the heated sensor
- Real-time trending complements blood gas sampling
- Auto-calibration keeps the sensor ready in the background
safeCLINITUBES capillary tubes
- Designed with rounded ends
References:
1. Ancel PY et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015; 169, 3: 230-238.
2. Fanaroff AA et al. NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007; 196, 2: 147.e
3. BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group, Stenson BJ, Tarnow-Mordi WO. Oxygen saturation and outcomes in preterm Infants. N Engl J Med 2013; 368, 22:2094-2104.
4. Holbek CC. 25 years of RADIOMETER blood gas analyzers. Aspects of biomedical engineering in Denmark 1998: 133–41.
1.
5. Severinghaus J et al. Blood gas analysis and critical care medicine. AM J Respir Crit Care Med 1998; 157: S114-S122.
Cookies are used on this website
Use of cookiesPlease enter a valid email
We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.
It seems that your e-mail is not registered with us
Please click "Get started" in the e-mail to complete the registration process
Radiometer is using Microsoft AZURE Active Directory to authenticate users
Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.
If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.
Key benefits
- Allow the use of existing Active Directory credentials
- Single-sign on experience
- Use same credentials to access future services
Request access
You will receive an invitation to access our services via e-mail when your request has been approved.
When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.